Source:http://linkedlifedata.com/resource/pubmed/id/21266577
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
15
|
pubmed:dateCreated |
2011-4-11
|
pubmed:abstractText |
Urate and myeloperoxidase (MPO) are associated with adverse outcomes in cardiovascular disease. In this study, we assessed whether urate is a likely physiological substrate for MPO and if the products of their interaction have the potential to exacerbate inflammation. Urate was readily oxidized by MPO and hydrogen peroxide to 5-hydroxyisourate, which decayed to predominantly allantoin. The redox intermediates of MPO were reduced by urate with rate constants of 4.6 × 10(5) M(-1) s(-1) for compound I and 1.7 × 10(4) M(-1) s(-1) for compound II. Urate competed with chloride for oxidation by MPO and at hyperuricemic levels is expected to be a substantive substrate for the enzyme. Oxidation of urate promoted super-stoichiometric consumption of glutathione, which indicates that it is converted to a free radical intermediate. In combination with superoxide and hydrogen peroxide, MPO oxidized urate to a reactive hydroperoxide. This would form by addition of superoxide to the urate radical. Urate also enhanced MPO-dependent consumption of nitric oxide. In human plasma, stimulated neutrophils produced allantoin in a reaction dependent on the NADPH oxidase, MPO and superoxide. We propose that urate is a physiological substrate for MPO that is oxidized to the urate radical. The reactions of this radical with superoxide and nitric oxide provide a plausible link between urate and MPO in cardiovascular disease.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Allantoin,
http://linkedlifedata.com/resource/pubmed/chemical/Hydrogen Peroxide,
http://linkedlifedata.com/resource/pubmed/chemical/NADPH Oxidase,
http://linkedlifedata.com/resource/pubmed/chemical/Peroxidase,
http://linkedlifedata.com/resource/pubmed/chemical/Superoxides,
http://linkedlifedata.com/resource/pubmed/chemical/Uric Acid
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1083-351X
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
286
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
12901-11
|
pubmed:meshHeading |
pubmed-meshheading:21266577-Allantoin,
pubmed-meshheading:21266577-Cardiovascular Diseases,
pubmed-meshheading:21266577-Humans,
pubmed-meshheading:21266577-Hydrogen Peroxide,
pubmed-meshheading:21266577-Hyperuricemia,
pubmed-meshheading:21266577-Inflammation,
pubmed-meshheading:21266577-NADPH Oxidase,
pubmed-meshheading:21266577-Neutrophils,
pubmed-meshheading:21266577-Oxidation-Reduction,
pubmed-meshheading:21266577-Peroxidase,
pubmed-meshheading:21266577-Substrate Specificity,
pubmed-meshheading:21266577-Superoxides,
pubmed-meshheading:21266577-Uric Acid
|
pubmed:year |
2011
|
pubmed:articleTitle |
Urate as a physiological substrate for myeloperoxidase: implications for hyperuricemia and inflammation.
|
pubmed:affiliation |
Free Radical Research Group, Department of Pathology, University of Otago, P. O. Box 4345, 8140 Christchurch, New Zealand.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|